首页 >
法规速递
-
Page: Supporting innovation-2025/2/11
2025-02-12查看详情 > -
Document: Consolidated 3-year work plan for the Emergency Task Force (ETF)-2025/2/11
2025-02-12查看详情 > -
Document: Minutes of the COMP meeting 3-5 December 2024-2025/2/11
2025-02-12查看详情 > -
Document: Agenda of the CVMP meeting 11-13 February 2025-2025/2/11
2025-02-12查看详情 > -
Document: Jakavi-H-C-002464-X-0070-G : EPAR - Assessment report - Variation-2025/2/11
2025-02-12查看详情 > -
Document: Applications for new human medicines under evaluation: February 2025-2025/2/10
2025-02-11查看详情 > -
Document: Agenda of the PRAC meeting 10-13 February 2025-2025/2/10
2025-02-11查看详情 > -
Page: Product-specific bioequivalence guidance-2025/2/10
2025-02-11查看详情 > -
Document: Methylphenidate, prolonged-release tablet 18 mg, 27 mg, 36 mg and 54 mg and modified release capsule 5 mg, 10 mg, 20 mg, 30 mg, 40 mg, 50 mg and 60 mg product-specific bioequivalence guidance-2025/2/10
2025-02-11查看详情 > -
Page: Medicines for human use under evaluation-2025/2/10
2025-02-11查看详情 >
